Moreover, in the tumor tissue, a relative reduction in IL17a+ pro-tumor T cells and an increase in the IFNγ+ subpopulation was observed, possibly linked to a potential increase in responses to checkpoint inhibitor blockers, which is typically ineffective in PC [117]. The gene discussed is IL17A; the disease is neoplasm.